Hypolipemiant besides antileukemic effect of imatinib mesylate

Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

Ellin Berman, Robert G. Maki, Martin Fleisher et al. · New England Journal of Medicine · 2006 · 317 citations · Full text

Medicine, Endocrinology, Oncology +17

Long-term imatinib therapy promotes bone formation in CML patients

Stephen Fitter, Andrea L. Dewar, P. Kostakis et al. · Blood · 2007 · 155 citations

Medicine, Oncology, Bone Metabolism +9

Imatinib Attenuates Diabetes-Associated Atherosclerosis

Markus Lassila, Terri J. Allen, Zemin Cao et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 143 citations

Life Sciences, Molecular Biology, Pharmacology +17

Imatinib as a potential antiresorptive therapy for bone disease

Andrea L. Dewar, Amanda Farrugia, Mark R. Condina et al. · Blood · 2006 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9